Quantcast

More News

CASI Pharmaceuticals gets approval for clinical trial

CASI Pharmaceuticals Inc., a Rockville-based biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products, received approval Monday from the Chinese National Medical Product Administration (NMPA), the Chinese counterpart to the U.S. Food and Drug Administration, for  a clinical ...

Read More »